Advertisement
Canada markets close in 2 hours 42 minutes

  • S&P/TSX

    22,035.20
    +163.24 (+0.75%)
     

  • S&P 500

    5,064.10
    +53.50 (+1.07%)
     

  • DOW

    38,474.52
    +234.54 (+0.61%)
     

  • CAD/USD

    0.7319
    +0.0017 (+0.24%)
     

  • CRUDE OIL

    83.03
    +1.13 (+1.38%)
     

  • Bitcoin CAD

    91,087.73
    +388.34 (+0.43%)
     

  • CMC Crypto 200

    1,436.59
    +21.83 (+1.54%)
     

  • GOLD FUTURES

    2,343.20
    -3.20 (-0.14%)
     

  • RUSSELL 2000

    2,002.92
    +35.45 (+1.80%)
     

  • 10-Yr Bond

    4.5760
    -0.0470 (-1.02%)
     

  • NASDAQ

    15,669.57
    +218.27 (+1.41%)
     

  • VOLATILITY

    16.25
    -0.69 (-4.07%)
     

  • FTSE

    8,044.81
    +20.94 (+0.26%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6836
    -0.0014 (-0.20%)
     
MARKETS LIVE BLOG:

STOCKS EXTEND GAINS AS RESULTS SEASON KICKS INTO HIGH GEAR

Tech-focused investors prepare for fresh wave of earnings highlighted by struggling Tesla

INNV Lawsuit Filed: Jakubowitz Law Pursues Claims on Behalf of Innovage Holding Inc. Shareholders

Newsfile Corp.
·2 min read

New York, New York--(Newsfile Corp. - November 29, 2021) - Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of InnovAge Holding Inc. (NASDAQ: INNV).

CLICK HERE FOR MORE DETAILS:

https://claimyourloss.com/securities/innovage-holding-inc-loss-submission-form/?id=21673&from=5

This lawsuit is on behalf of persons and entities that purchased or otherwise acquired InnovAge common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's March 2021 initial public offering.

Shareholders interested in representing the class of wronged shareholders have until December 13, 2021 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

ADVERTISEMENT

According to a filed complaint, InnovAge Holding Inc. issued materially false and/or misleading statements and/or failed to disclose that: (1) certain of InnovAge's facilities failed to provide covered services, provide accessible and adequate services, manage participants' medical situations, and oversee use of specialists; (2) as a result, the Company was reasonably likely to be subject to regulatory scrutiny, including by the Centers for Medicare and Medicaid Services; (3) as a result, there as a significant risk that CMS would suspend new enrollments pending an audit of the Company's services; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/105612